We are live on ! Find out more
Aaron Cowen

Aaron Cowen Suvretta Capital Management

AUM $4.3B Turnover 27.78%
1-Year Est. Return 63.88%
 

Aaron Cowen is the founder of Suvretta Capital Management, a long/short equity firm with a fundamental research process. The firm invests across sectors with an emphasis on differentiated fundamental views. Cowen’s disclosures are tracked by investors who follow mid-to-large fundamental hedge funds.

This Fund
S&P 500
This Quarter Est. Return
-7.01%
1 Year Est. Return
+63.88%
3 Year Est. Return
+352.91%
5 Year Est. Return
+470.77%
10 Year Est. Return
+2,330.02%
AUM
$4.3B
AUM Growth
-$1.17B
Cap. Flow
-$658M
Cap. Flow %
-15.3%
Top 10 Hldgs %
53.48%
Holding
108
New
12
Increased
17
Reduced
31
Closed
18
Avg Time Held Equity + Options
1.9 years
Top 10 Avg Time Held Equity + Options
0.7 years
Top 20 Avg Time Held Equity + Options
1.2 years
Avg Time Held Equity only
1.9 years
Top 10 Avg Time Held Equity only
0.8 years
Top 20 Avg Time Held Equity only
1.2 years

Top Buys

Rank Stock Value
1
SPCX icon
SpaceX
SPCX
+$49.5M
2
REPL icon
Replimune Group
REPL
+$48M
3
MLM icon
Martin Marietta Materials
MLM
+$40.1M
4
BURL icon
Burlington
BURL
+$31M
5
CCL icon
Carnival
CCL
+$29.1M

Sector Composition

Rank Sector Weight
1 Healthcare 52.88%
2 Miscellaneous 17.11%
3 Technology 9.61%
4 Consumer Discretionary 4.62%
5 Communication Services 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GWW icon
101
W.W. Grainger
GWW
$66.7B
– –
-770
Closed -$1.05M –
INM icon
102
DELISTED
InMed Pharmaceuticals
INM
– –
-10,000
Closed -$155K –
NTRA icon
103
Natera
NTRA
$42B
– –
-10,100
Closed -$2.74M –
RCUS icon
104
Arcus Biosciences
RCUS
$2.27B
– –
-4,776,423
Closed -$147M –
TMO icon
105
Thermo Fisher Scientific
TMO
$255B
– –
-13,400
Closed -$6.72M –
UNH icon
106
UnitedHealth
UNH
$296B
– –
-64,130
Closed -$26.7M –
TRLV icon
107
Trulieve Cannabis
TRLV
$1.6B
– –
-356,100
Closed -$3.5M –
KARD
108
Kardigan
KARD
$1.17B
– –
-400,000
Closed -$9.5M –

Similar funds

Aaron Cowen's Q3 2026 Portfolio in Review

As of Q3 2026, Aaron Cowen held 108 positions worth $4.3B, down 21% from $5.47B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Aaron Cowen withdrew a net $658M in Q3 2026, closing 18 positions and reducing 31 holdings. Its most notable exit was Advanced Micro Devices, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 55% a quarter earlier, followed by Miscellaneous and Technology.

Against the trend, Aaron Cowen opened a new position in Burlington worth $26.6M.

  • Aaron Cowen's largest Q3 2026 buy was Burlington: 99,700 shares worth $26.6M.
  • Aaron Cowen added most to SpaceX in Q3 2026, an estimated $49.5M increase.
  • Aaron Cowen's biggest Q3 2026 reduction was Home Depot, cutting an estimated $72.5M.
  • Aaron Cowen fully exited Advanced Micro Devices in Q3 2026, selling an estimated $149M.
  • Aaron Cowen's ten largest holdings make up 53% of its $4.3B portfolio in Q3 2026.
  • Aaron Cowen opened 12 new positions and closed 18 in Q3 2026.
  • Aaron Cowen's portfolio value fell 21% quarter-over-quarter to $4.3B.

Based on Suvretta Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.